Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market 2025-08-01 20:00
Atombeat and BioDuro Announce Strategic Partnership to Launch an AI-Powered Platform for Accelerated Peptide Drug Discovery 2025-08-01 18:08
Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease 2025-08-01 15:52
Neurophet Showcases Full-Cycle Brain Imaging Analysis Solutions for Alzheimer's disease Including 'Neurophet AQUA AD' at AAIC 2025 2025-07-31 21:00
Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical Development 2025-07-31 17:55
OMRON Healthcare's Smart Devices Help Detect Early Heart Failure Risks in Over 33% of Study Participants 2025-07-31 16:00
Akeso Announces Completion of First Dosing in Phase III Clinical Trial of Ivonescimab (PD-1/VEGF) Combination Therapy for Immunotherapy-Resistant NSCLC 2025-07-31 09:46
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure 2025-07-31 04:10
BON Launches AI-Powered New Drug Research and Development 2025-07-30 21:00
Harbour BioMed to Present Phase II Data of HBM4003 and Tislelizumab Combination in MSS Metastatic Colorectal Cancer at ESMO 2025 2025-07-30 08:01
Fapon to Debut Shine mT8000 Open-Access, High Throughput Clinical Chemistry and Immunoassay Analyzer at ADLM 2025 2025-07-29 18:00
XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury 2025-07-28 21:10
Big Lake Capital, LLC, Led and Controlled by NMHI CEO, Converts $671,984 Note into Nature's Miracle ("NMHI") Common Stocks 2025-07-28 20:30
World's First Engineered Exosome for Hair Growth & Localized Fat Reduction Secure INCI Designation: ImmVira Accelerates Access to Billion-Dollar Aging-related Market 2025-07-28 20:28
Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat 2025-07-28 17:51
Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)' 2025-07-28 14:00
NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer 2025-07-28 12:14
Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule GLP-1R Agonist ASC30 2025-07-28 08:15
Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results 2025-07-28 08:11
Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint 2025-07-25 20:30